刘思燚;张红柱;范菁;尚展鹏;王菲;李玮婕;刘颖;卢建秋;张加余;
LIU Si-yi;ZHANG Hong-zhu;FAN Jing;SHANG Zhan-peng;WANG Fei;LI Wei-jie;LIU Ying;LU Jian-qiu;ZHANG Jia-yu;Beijing University of Chinese Medicine;Center for Drug Evaluation,China Food and Drug Administration;The First Hospital of Fangshan District;Wu Xi App Tec;

• 1:北京中医药大学
• 2:国家食品药品监督管理总局药品审评中心
• 3:北京市房山区第一医院
• 4:上海药明康德新药开发有限公司

摘要(Abstract)：

应用细胞生物色谱法及UHPLC-LTQ-Orbitrap质谱联用技术快速筛选鉴定苦碟子注射液中可能的活性成分。选择人脐静脉内皮细胞(huma umbilical vein endothelid cells,HUVEC)作为靶细胞,先使苦碟子注射液中的活性成分与靶细胞特异性结合,经细胞靶点脱敏失活后,应用LC-MS快速鉴定与细胞靶向亲和的化学成分,从而筛选得到苦碟子注射液中可能的活性成分。根据获得的精确相对分子质量数据、保留时间以及结合苦碟子注射液中的化学成分进行鉴定归属。最终,从细胞裂解液中共筛选鉴定出9个化学成分,其中包括倍半萜内酯类成分4个、有机酸类成分3个以及黄酮类成分2个。应用细胞生物色谱法与UHPLC-LTQ-Orbitrap质谱联用技术快速筛选鉴定苦碟子注射液中可能的活性成分,可为苦碟子注射液药效物质基础研究提供一种快捷、有效的方法学借鉴。
An effective method has been employed as a tool for screening active components in Kudiezi injection by using cell chromatography and sensitive UHPLC-HR-MSnmethod. The potential bioactive components in Kudiezi injection could be selectively bound to the HUVECs target cells first. After cell target desensitization and inactivation,the chemical constituents with cell target affinity were identified by LC-MS,so as to screen the possible active components in Kudiezi injection. Based on the accurate mass measurements and the retention time,in total,9 compounds were tentatively identified and characterized,including 4 sesquiterpene lactones,3 phenolic acids and 2 flavonoids. HUVECs biospecific extraction coupled with UHPLC-LTQ-Orbitrap analysis could provide a rapid and efficient method for the identification of potential bioactive components in Kudiezi injection,and provide the reference for further research on its effective materials basis.

关键词(KeyWords)： 苦碟子注射液;人脐静脉内皮细胞;细胞生物色谱法;液质联用技术
Kudiezi injection;HUVECs;cell chromatography;UHPLC LTQ orbitrap

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金项目(81503244);; 国家重点基础研究发展计划(973)项目(2012CB518406);; 2017年北京市科技新星与领军人才培养专项计划(Z171100001117029)

作者(Authors): 刘思燚;张红柱;范菁;尚展鹏;王菲;李玮婕;刘颖;卢建秋;张加余;
LIU Si-yi;ZHANG Hong-zhu;FAN Jing;SHANG Zhan-peng;WANG Fei;LI Wei-jie;LIU Ying;LU Jian-qiu;ZHANG Jia-yu;Beijing University of Chinese Medicine;Center for Drug Evaluation,China Food and Drug Administration;The First Hospital of Fangshan District;Wu Xi App Tec;

DOI: 10.19540/j.cnki.cjcmm.20170801.001

参考文献(References)：

• [1]蔡伟.苦碟子倍半萜内酯类似物靶向分离及体内代谢研究[D].北京:北京中医药大学,2015.
• [2]刘颖,王青,王放,等.苦碟子注射液HPLC指纹图谱与化学模式识别分析[J].中国药学杂志,2013,48(24):2097.
• [3]王放,张加余,王青,等.HPLC-HR-MSn法鉴定苦碟子注射液中酚酸类成分[J].中南药学,2013,11(8):561.
• [4]刘思燚,张秀平,尚展鹏,等.UHPLC-LTQ-Orbitrap鉴定苦碟子注射液化学成分及其在大鼠血浆中的移行成分[J].中国中药杂志,2016,41(12):2235.
• [5]Wang F,Zhang J Y,Yin P H,et al.Rapid identification of polyphenols in Kudiezi injection with a practical technique of mass defect filter based on high-performance liquid chromatography coupled with linear ion trap/orbitrap mass spectrometry[J].Anal Methods,2014,6(10):3515.
• [6]Cai W,Zhang J Y,Liu Y,et al.Metabolic profiles of 11,13α-dihydroixerin Z in rats using high performance liquid chromatography-LTQ-orbitrap mass spectrometry[J].Anal Methods,2016,8(4):854.
• [7]刘颖,卢建秋,张加余,等.苦碟子药材及其注射液中化学成分的HPLC-ESI-MSn分析[J].中国中药杂志,2013,38(16):2675.
• [8]Li S L,Li P,Sheng L H,et al.Live cell extraction and HPLCMS analysis for predicting bioactive components of traditional Chinese medicines[J].J Pharm Biomed Anal,2006,41(2):576.
• [9]Li F,Tan Y S,Chen H L,et al.Identification of schisandrin as a vascular endothelium protective component in Yi Qi Fu Mai powder injection using HUVECs binding and HPLC-DAD-Q-TOFMS/MS analysis[J].J Pharmacol Sci,2015,129(1):1.
• [10]Hong M,Wang X Z,Wang L,et al.Screening of immunomodulatory components in Yu-ping-feng-san using splenocyte binding and HPLC[J].J Pharm Biomed Anal,2011,54(1):87.
• [11]岳宣峰.基于HUVECM和色谱质谱联用的药物筛选模型的建立及其应用[D].西安:陕西师范大学,2009.
• [12]Heilmann J,Merfort I,Weiss M.Radical scavenger activity of different 3,4-dihydroxyf lavonols and 1,5-dicaffeoylquinic acid studied by inhibition of chemiluminescence[J].Planta Med,1995,61(5):435.
• [13]Hatano T,Yauhara T,Yoshihara R,et al.Effects of interaction of tannis with co-existing substances:inhibitory effects of tannins and related polyphenols on xanthine oxidase[J].Chem Pharm Bull,1990,38(5):1224.
• [14]Cornicelli J A,Trivedi B K.15-Lipoxygenase and its inhibition:a novel therapeutic target for vascular disease[J].Curr Pharm Des,1999,5(1):11.
• [15]Akesson C,Lindgren H,Pero R W,et al.Quinic acid is a biologically active component of the uncariatomentosa extract C-Med100[J].Int Immunopharmacol,2005,5(1):219.
• [16]于玲玲,王学东,王淞林,等.木犀草素-7-O-β-D-葡萄糖醛酸苷治疗脑梗塞的用途:中国,CN 102327281A[P].2012-01-25.
• [17]陈曦.旋覆花中倍半萜内酯类成分的抗炎作用及其机制研究[D].天津:天津医科大学,2016.
• [18]于佳澜.苦碟子对缺氧损伤血管内皮细胞的保护作用及PKCδ/MARCKS通路的调节[D].北京:北京中医药大学,2013.
• [19]刘亚琼,朱陵群,张允岭,等.苦碟子注射液对人脑微血管内皮细胞高糖损伤后核因子-κB及黏附分子表达的影响[J].中华中医药杂志,2010,25(2):204.
• [20]Zheng Z G,Duan T T,He B,et al.Macrophage biospecific extraction and HPLC-ESI-MSnanalysis for screening immunological active components in Smilacis Glabrae Rhizoma[J].J Pharm Biomed Anal,2013,77(2):44.
• [21]闵春艳.茵陈蒿汤人肝细胞膜固相色谱研究[D].南京:南京中医药大学,2004.
• [22]陈英红,罗浩铭,王颖,等.苦碟子注射液不同活性组分对大鼠脑神经细胞保护作用的实验研究[J].中国中医药科技,2016,23(4):421.
• [23]罗浩铭.苦碟子注射液中有效物质基础的研究[D].长春:吉林大学,2010.